Advertisements


Roche Holding"s (RHHBY) Virtual Late Stage Pipeline Event 2018 - Slideshow

Roche Holding"s (RHHBY) Virtual Late Stage Pipeline Event 2018 - Slideshow.....»»

Category: topSource: seekingalphaSep 14th, 2018

Roche Holding Ltd (RHHBY) Management on Virtual Pipeline Event 2018 World Conference on Lung Cancer Conference Call (Transcript)

Roche Holding Ltd (RHHBY) Management on Virtual Pipeline Event 2018 World Conference on Lung Cancer Conference Call (Transcript).....»»

Category: topSource: seekingalphaSep 26th, 2018

Roche Holding Ltd ADR (RHHBY) Presents At 2019 ASCO Annual Meeting - Slideshow

Roche Holding Ltd ADR (RHHBY) Presents At 2019 ASCO Annual Meeting - Slideshow.....»»

Category: topSource: seekingalphaJun 6th, 2019

Roche Holding"s (RHHBY) CEO Severin Schwan on Q1 2018 Results - Earnings Call Transcript

Roche Holding"s (RHHBY) CEO Severin Schwan on Q1 2018 Results - Earnings Call Transcript.....»»

Category: topSource: seekingalphaApr 27th, 2018

Roche Holding ADR (RHHBY) Presents At Deutsche Bank Securities Inc. DbAccess Berlin Conference - Slideshow

Roche Holding ADR (RHHBY) Presents At Deutsche Bank Securities Inc. DbAccess Berlin Conference - Slideshow.....»»

Category: topSource: seekingalphaJun 6th, 2018

Roche"s Tecentriq Met Primary Goal in First-Line NSCLC Study

Roche's (RHHBY) late-stage lung cancer study on immuno-oncology drug, Tecentriq, meets its co-primary endpoint of progression-free survival (PFS). Roche H.....»»

Category: dealsSource: nytJul 19th, 2018

Roche Holding Ltd ADR (RHHBY) CEO Severin Schwan on Q2 2018 Results - Earnings Call Transcript

Roche Holding Ltd ADR (RHHBY) CEO Severin Schwan on Q2 2018 Results - Earnings Call Transcript.....»»

Category: topSource: seekingalphaJul 26th, 2018

Roche Announces Positive Data on Breast Cancer Drug Kadcyla

Roche's (RHHBY) breast cancer drug Kadcyla, in a late-stage study in patients suffering from HER2-positive eBCmet, met its goal. Roche RHHBY announced encouraging results from a phase III st.....»»

Category: smallbizSource: nytOct 16th, 2018

Roche Holding Ltd (RHHBY) CEO Severin Schwan on Q3 2018 Results - Earnings Call Transcript

Roche Holding Ltd (RHHBY) CEO Severin Schwan on Q3 2018 Results - Earnings Call Transcript.....»»

Category: topSource: seekingalphaOct 18th, 2018

Roche Holding Ltd (RHHBY) Management Presents at 2018 American Society of Hematology"s 60th Annual Meeting Conference (Transcript)

Roche Holding Ltd (RHHBY) Management Presents at 2018 American Society of Hematology"s 60th Annual Meeting Conference (Transcript).....»»

Category: topSource: seekingalphaDec 5th, 2018

Roche Holding Ltd ADR (RHHBY) CEO Severin Schwan on Q4 2018 Results - Earnings Call Transcript

Roche Holding Ltd ADR (RHHBY) CEO Severin Schwan on Q4 2018 Results - Earnings Call Transcript.....»»

Category: topSource: seekingalphaFeb 1st, 2019

The Daily Biotech Pulse: Roche"s Flu Drug Aces Late-Stage Trial, Acura Outlicenses Pain Medication, Neuronetics Gets New Finance Chief

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on July 2) read more.....»»

Category: blogSource: benzingaJul 3rd, 2019

Financial Markets To Federal Reserve: Time To Start Cutting Rates

Authored by John Rubino via DollarCollapse.com, In late 2018 the US stock market tanked, in effect holding a gun to its own head and threatening to pull the trigger unless the Fed stopped raising interest rates. The Fed, painfully aware.....»»

Category: blogSource: zerohedgeMay 28th, 2019

Raymond James Downgrades Ocular Therapeutix, Remains Bullish On Pipeline

Ocular Therapeutix Inc (NASDAQ: OCUL)'s failure to ace a late-stage study of its glaucoma treatment candidate has tempered Raymon.....»»

Category: blogSource: benzingaMay 21st, 2019

Myovant Shares Slide Despite Positive Late-Stage Data For Menstrual Bleeding Drug

Myovant Sciences Ltd (NYSE: MYOV) shares were trading sharply lower Tuesday despite seemingly positive news on the company'sĀ pipeline candidate for menstrual bleeding in women with uterine fibroids. read more.....»»

Category: blogSource: benzingaMay 14th, 2019

TG Therapeutics: Varied Pipeline With 2 Lead Candidates In Late Stage, Low Cash Position

TG Therapeutics: Varied Pipeline With 2 Lead Candidates In Late Stage, Low Cash Position.....»»

Category: topSource: seekingalphaMay 14th, 2019

Roche Holding AG (RHHBY) CEO Severin Schwan on Q1 2019 Results - Earnings Call Transcript

Roche Holding AG (RHHBY) CEO Severin Schwan on Q1 2019 Results - Earnings Call Transcript.....»»

Category: topSource: seekingalphaApr 17th, 2019

Aclaris Therapeutics (ACRS) Presents At William Blair Late-Stage Therapeutics Conference - Slideshow

Aclaris Therapeutics (ACRS) Presents At William Blair Late-Stage Therapeutics Conference - Slideshow.....»»

Category: topSource: seekingalphaApr 4th, 2019

Eyenovia Reports Fourth Quarter and Full Year 2018 Financial Results

NEW YORK, March 27, 2019 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ:EYEN), a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose therapeutics utilizing its patented piezo-pri.....»»

Category: earningsSource: benzingaMar 27th, 2019

Y-mAbs Announces 2018 Financial Results and Corporate Development Highlights

NEW YORK, March 22, 2019 (GLOBE NEWSWIRE) -- Y-mAbs Therapeutics, Inc. (the "Company" or "Y-mAbs") (NASDAQ:YMAB) a late-stage clinical bioph.....»»

Category: earningsSource: benzingaMar 22nd, 2019

Eisai Launches Confirmatory Late-Stage Trial Of Second Alzheimer"s Asset After Setback

Undeterred by the failure of one of its Alzheimer's pipeline assets, Eisai Co., Ltd (OTC: ESALY) is stepping up efforts to further advanceĀ its clinical pipeline. read more.....»»

Category: blogSource: benzingaMar 22nd, 2019